As of 2025-09-16, the Relative Valuation of Kinnate Biopharma Inc (KNTE) is (65.08) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.65 USD, the upside of Kinnate Biopharma Inc based on Relative Valuation is -2555.7%.
The range of the Relative Valuation is (63.76) - (63.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.3x - 26.8x | 24.5x |
| Forward P/E multiples | 26.7x - 32.3x | 30.0x |
| Fair Price | (63.76) - (63.95) | (65.08) |
| Upside | -2506.2% - -2513.4% | -2555.7% |
| Date | P/E |